A Novel Charged Sodium-Channel Blocker, Ntx-1175, Is Effective In Reducing Acute Visceral Hypersensitivity In Vivo

Ehsan Noor-Mohammadi(University of Oklahoma Health Sciences Center), Anthony C. Johnson(University of Oklahoma Health Sciences Center), Jim R. Ellis(Centre for Environment, Fisheries and Aquaculture Science), Casey O. Ligon(University of Oklahoma Health Sciences Center), Bridget Cole(Pfizer (United States)), Nan Zheng, Beverley Greenwood–Van Meerveld(University of Oklahoma)
Journal of Pharmacology and Experimental Therapeutics
May 18, 2023
Cited by 1


Related Papers